Posted by Caren Woodson
Last week the Department of Justice issued new guidelines to U.S. Attorneys concerning investigations and prosecutions in states that have authorized the use of cannabis for therapeutic purposes. These guidelines are a positive step in the right direction, but more needs to be done to ensure real and lasting protection for patients and their providers in medical cannabis states. In particular, individuals accused of violating federal marijuana laws must be permitted to use evidence in federal court to demonstrate that their use of medical marijuana followed state law and was used to alleviate suffering. To that end, U.S. Representative Sam Farr (D-CA), and a bipartisan group of his colleagues, re-introduced the “Truth in Trials” bill in the U.S. House of Representatives today.